BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients

被引:6
|
作者
Lopez-Munoz, Eunice [1 ]
Hernandez-Zarco, Adelina [1 ]
Garcia-Hernandez, Normand [1 ]
Alvarado-Cabrero, Isabel [2 ]
Zarco-Espinosa, Gelasio [3 ]
Salamanca-Gomez, Fabio
Arenas-Aranda, Diego [1 ]
机构
[1] Hosp Pediat Mexico City, Unidad Invest Med Genet Humana, Ctr Med Nacl Siglo XXI CMN S XXI, Inst Mexicano Seguro Social IMSS, Mexico City 06720, DF, Mexico
[2] Hosp Oncol, Serv Patol, CMN SXXI, IMSS, Mexico City 06720, DF, Mexico
[3] Hosp Oncol, Serv Tumores Mama, CMN S XXI, IMSS, Mexico City 06720, DF, Mexico
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2012年 / 14卷 / 08期
关键词
BIK/NBK; Estrogen receptor; Breast cancer; ENDOPLASMIC-RETICULUM BIK; BCL-2 PROTEIN FAMILY; CELL-DEATH; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; MITOCHONDRIAL APOPTOSIS; PROTEASOME INHIBITORS; AROMATASE INHIBITORS; BH3-ONLY PROTEIN; DRUG-RESISTANCE;
D O I
10.1007/s12094-012-0845-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study is to determine the association between the BIK/NBK gene expression and estrogen receptor alpha expression. We determined the association of BIK/NBK gene expression by real time quantitative reverse transcription polymerase chain reaction and estrogen receptor alpha expression by immunohistochemistry in samples of breast cancer tissue. We found a statistically significant correlation of BIK/NBK gene expression with the estrogen receptor alpha expression (rho = 0.751, p = 0.004). For verify differences of BIK/NBK gene expression among ER alpha+ and ER alpha- breast cancer tissues, Mann-Whitney U test was performed, obtaining significant differences. BIK/NBK gene expression may have important clinical implications and provide predictive, prognostic or therapeutic marker in breast cancer patients according to the estrogen receptor alpha expression.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [41] Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
    Portella, G.
    Passaro, C.
    Chieffi, P.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (04) : 482 - 496
  • [42] Telomerase: A potential molecular marker and therapeutic target for cancer
    Chang, JY
    JOURNAL OF SURGICAL ONCOLOGY, 2004, 87 (01) : 1 - 3
  • [43] Significance of PSCA as a novel prognostic marker and therapeutic target for cancer
    Dizaj, Tina Nayerpour
    Doustmihan, Abolfazl
    Oskouei, Behnaz Sadeghzadeh
    Akbari, Morteza
    Jaymand, Mehdi
    Mazloomi, MirAhmad
    Jahanban-Esfahlan, Rana
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [44] ERb and breast cancer: A potential predictive and prognostic biomarker and novel therapeutic drug target
    Hawse, J. R.
    Subramaniam, M.
    Reese, J. M.
    Wu, X.
    Negron, V.
    Gingery, A.
    Pitel, K. S.
    Shah, S. S.
    Cunliffe, H. E.
    McCullough, A. E.
    Pockaj, B. A.
    Couch, F. J.
    Reynolds, C.
    Lingle, W. L.
    Suman, V. J.
    Spelsberg, T. C.
    Goetz, M. P.
    Ingle, J. N.
    CANCER RESEARCH, 2013, 73
  • [45] IL-17, an important prognostic factor and potential therapeutic target for breast cancer?
    Bian, Geng
    Zhao, Wen-Ying
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (02) : 604 - 605
  • [46] Identification of KCNK1 as a potential prognostic biomarker and therapeutic target of breast cancer
    Sun, Xinyuan
    Li, Yizhi
    Lan, Hua
    Jiang, Ting
    Wan, Xiaoya
    Cheng, Yan
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 241
  • [48] Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
    Hoffmeister-Wittmann, Paula
    Mock, Andreas
    Nichetti, Federico
    Korell, Felix
    Heilig, Christop E.
    Scherr, Anna-Lena
    Gunther, Michael
    Albrecht, Thomas
    Kelmendi, Eblina
    Xu, Kaiyu
    Nader, Luisa
    Kessler, Annika
    Schmitt, Nathalie
    Fritzsche, Sarah
    Weiler, Sofia
    Sobol, Benjamin
    Stenzinger, Albrecht
    Boeck, Stefan
    Westphalen, Christoph B.
    Schulze-Osthoff, Klaus
    Trojan, Jorg
    Kindler, Thomas
    Weichert, Wilko
    Spiekermann, Karsten
    Bitzer, Michael
    Folprecht, Gunnar
    Illert, Anna-Lena
    Boerries, Melanie
    Klauschen, Frederick
    Ochsenreiter, Sebastian
    Siveke, Jens
    Bauer, Sebastian
    Glimm, Hanno
    Brors, Benedikt
    Huellein, Jennifer
    Huebschmann, Daniel
    Uhrig, Sebastian
    Horak, Peter
    Kreutzfeld, Simon
    Banales, Jesus M.
    Springfeld, Christoph
    Jaeger, Dirk
    Schirmacher, Peter
    Roessler, Stephanie
    Ormanns, Steffen
    Goeppert, Benjamin
    Froehling, Stefan
    Koehler, Bruno C.
    LIVER INTERNATIONAL, 2022, 42 (12) : 2855 - 2870
  • [49] CRD-BP as a potential prognostic marker and therapeutic target in melanoma
    Xu, Y. G.
    Kim, T.
    Setaluri, V.
    Spiegelman, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S110 - S110
  • [50] SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
    Jiang, Ming
    Wang, Huiju
    Chen, Hong
    Han, Yong
    AGING-US, 2020, 12 (20): : 20835 - 20861